Reducing Barriers to Drug Abuse Treatment Services (RBP)

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Wright State University
ClinicalTrials.gov Identifier:
NCT00273845
First received: January 5, 2006
Last updated: February 23, 2009
Last verified: February 2009

January 5, 2006
February 23, 2009
May 2003
May 2008   (final data collection date for primary outcome measure)
Linkage and Retention in substance abuse treatment [ Time Frame: 3 months, 6 months ] [ Designated as safety issue: No ]
Retention and Engagement in substance abuse treatment
Complete list of historical versions of study NCT00273845 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Reducing Barriers to Drug Abuse Treatment Services
Reducing Barriers to Drug Abuse Treatment Services

The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engagement" represents a more comprehensive conceptualization of "treatment retention" and includes measures of the clinical and ancillary services actually received by the client over time; as such, client engagement focuses on the intensity and duration of treatment participation. This study will enhance the CIU concept by conducting a controlled trial, using a three-armed research design, of interventions designed to enhance treatment linkage and treatment engagement. These interventions - a Motivational Intervention and Strengths-Based Case Management - are science-based and have demonstrated efficacy in moving drug abusers towards treatment and supporting treatment engagement.

The Specific Aims of the project are:

  1. To conduct a detailed qualitative/ethnographic investigation to study: (a) the processes and factors operant in a person's decision to link with a substance abuse treatment agency once a formal (i.e., professional) assessment and referral have been made; and (b) the processes and factors operant in staying in treatment once it has been initiated.
  2. To identify and classify, using quantitative methods, the operant barriers to treatment linkage and engagement. We will assess the factors that are associated with these barriers and examine the effects of the study's interventions on removing them.
  3. To evaluate the effectiveness, using a controlled trial, of a Motivational Intervention and Strengths-Based Case Management, compared to the CIU's "standard" referral process, by examining differences between the Standard, Motivational Intervention, and Case Management conditions on treatment linkage and engagement outcomes. The conceptual framework for this controlled trial is the well-studied Andersen model of access and health service use, modified for chemical dependency services (Andersen, 1995). The interventions are designed to affect mutable factors such as perceived barriers to treatment. Data will be collected at baseline, and at 3 and 6 months thereafter. Analyses will examine whether the interventions work better with different groups of clients (e.g. cocaine users versus marijuana users, males versus females, different ethnicities, etc); as well as different treatment modalities (standard outpatient versus intensive outpatient.)
  4. To conduct a quantitative investigation of the effects of Individual Level and Health Care System Level factors that predict treatment linkage and engagement in the context of the proposed interventions. This study component will develop comprehensive models to predict how these factors interact with the study's interventions to effect treatment linkage and treatment engagement.
Interventional
Phase 2
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Substance Abuse
  • Behavioral: Motivational interviewing
    One session
  • Behavioral: Strengths-Based Case Management
    5 sessions
  • Experimental: 1
    One session of motivational interviewing
    Intervention: Behavioral: Motivational interviewing
  • Experimental: 2
    Five sessions of strengths-based case management
    Intervention: Behavioral: Strengths-Based Case Management
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
678
May 2008
May 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • substance abuse or dependence per DSM-IVR criteria

Exclusion Criteria:

  • active thought disorder
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00273845
02-407-10, 1R01DA15690, HSP 2527
Yes
Marianne Shreck, Wright State University
Wright State University
National Institute on Drug Abuse (NIDA)
Principal Investigator: Richard C Rapp, M.S.W. Boonshoft School of Medicine, Wright State University
Wright State University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP